ARCHIVES

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980

NCAB Committee Close To Definition Of QRA

February 11, 1983

NIH director; Targets Increases Favor Established Researchers

May 9, 1997

FDA Approves Votrient For Renal Cell Carcinoma

October 23, 2009

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

November 9, 1979

Statement Defining Cancer Control Goals, Approaches Okayed By Board

February 6, 1981